Propel Bio Management, LLC Abeona Therapeutics Inc. Transaction History
Propel Bio Management, LLC
- $172 Billion
- Q3 2024
A detailed history of Propel Bio Management, LLC transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Propel Bio Management, LLC holds 624,022 shares of ABEO stock, worth $3.67 Million. This represents 2.29% of its overall portfolio holdings.
Number of Shares
624,022
Previous 1,248,044
50.0%
Holding current value
$3.67 Million
Previous $5.29 Billion
25.47%
% of portfolio
2.29%
Previous 3.43%
Shares
2 transactions
Others Institutions Holding ABEO
# of Institutions
61Shares Held
26.8MCall Options Held
614KPut Options Held
45K-
Suvretta Capital Management, LLC New York, NY3.69MShares$21.7 Million0.92% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.43MShares$20.2 Million1.29% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.25MShares$19.1 Million0.04% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.3MShares$13.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.01MShares$11.8 Million0.0% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $35M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...